Reddit's popularity as a tool for self-managing inflammatory bowel disease highlights opportunities for improvements in ...

DelveInsight’s “Crohn's Disease Market Insights, Epidemiology, and Market Forecast–2034” provides a comprehensive analysis of ...

"I thought it was the end of the world," he said at the time. But now he is happy to talk about the impact of his condition ...

Objective Certain leading medical organisations are considering alternatives to the Body Mass Index (BMI) as a predictor of the risk for non-communicable chronic disease (NCD) or death. Our objective ...

The NHS is offering three Covid treatments as the "more infectious" Nimbus variant continues to spread across the UK. The ...

The NHS continues to offer three Covid treatments as the 'more infectious' Nimbus variant continues to spread across the UK.

The presence of IBD among patients with axSpA was not linked to an increased risk for active axSpA or radiographic progression.

Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome. In an effort to develop targeted treatments for gut pain, scientists have ...

Eli Lilly’s Omvoh (mirikizumab-mrkz) has shown continued benefit after four years in a Phase III open-label extension trial ...

Merck broadens its tulisokibart clinical program with three new phase IIb studies, deepening its reach across immune-mediated ...

Roche's entry into the category with afimkibart (RG6631) stemmed from its purchase of Telavant for $7.1 billion, and since ...

New data from Eli Lilly and Company (NYSE: LLY) showed Omvoh (mirikizumab-mrkz) is the first and only interleukin-23p19 ...